Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Leukemia|August 21, 2020
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational studyAlessandro M Vannucchi, Benedetta Sordi, Alessandro Morettini, et al.
Haematologica|May 14, 2016
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutationAlberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, et al.
American Journal of Hematology|November 24, 2016
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasmsLisa Pieri, Chiara Paoli, Umberto Arena, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 10, 2018
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' projectFrancesca Palandri, Giulia Benevolo, Alessandra Iurlo, et al.
Leukemia Research|November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Pageof 3